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Abstract
Background: Solid pseudopapillary neoplasms (SPN) of the pancreas are rare pancreatic neoplasms where
complete resection is the cornerstone in management. It has been demonstrated in previous studies that minimally
invasive surgical approaches are effective management options in treating SPNs of the distal pancreas. The purpose
of this study is to evaluate the feasibility of minimally invasive surgery in treating SPNs of the uncinate, head, and
neck of the pancreas.
Methods: Data from 2005 to 2017 at Severance Hospital of the Yonsei University Health systems in Seoul, South
Korea, were retrospectively collected for 25 patients who were diagnosed with SPN of the uncinate, head, and neck
of the pancreas and who underwent curative resection. Three groups of patients were considered, depending on
the year of surgery, in order to determine trends in the surgical management of SPN. The patients were also
divided into two groups corresponding to the type of operation done (minimally invasive surgery vs. open surgery).
Perioperative patient data, including age, gender, body mass index (BMI), tumor size, and operation done, were
compared and analyzed statistically. Long-term nutritional effects were measured using the Controlling Nutritional
Status (CONUT) scoring system.
Results: There were no statistically significant differences in age, gender, BMI, symptomatic presentation, operation
type, tumor size, and tumor stage between the three time periods. In comparing between minimally invasive and
open surgery, there were no statistically significant differences in age, gender, symptomatic presentation, BMI,
tumor size, preoperative stage, type of operation, operation time, pancreatic duct size, post-operative pancreatic
fistula (POPF) grade, death associated with disease, recurrence, pathological parameters, and change in CONUT
score. There was a significant difference in tumor size (4.5 ± 1.8 vs. 2.6 ± 1.0 cm, p = 0.004), blood loss (664.2 ± 512.4
vs. 277.7 ± 250.8 mL, p = 0.024), need to transfuse (33% vs. 0%, p = 0.023), hospital length of stay (27.4 ± 15.3 vs.
11.5 ± 5.3 days, p = 0.002), and complication rate (75% vs. 30.8%, p = 0.027) between the two groups.
Conclusions: In appropriately selected patients with SPNs of the uncinate, head, and neck of the pancreas, a
minimally invasive surgical approach offers at least equal oncologic and nutritional outcomes, while demonstrating
decreased complications and decreased hospital length of stay compared with that of an open surgical approach.
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Background
Neoplasms of the pancreas are the fourth most
common cause of cancer-related death globally [1].
These tumors are often difficult to detect due to
their location; most patients present with non-spe-
cific symptoms or clinicians discover them on
incidental radiographs for different conditions [2, 3].
Solid pseudopapillary neoplasm (SPN) of the pan-
creas, also referred to as Frantz’s tumor, is rare,
comprising 1–2% of all pancreatic tumors [4–6].
SPNs of the pancreas are usually diagnosed in fe-
males who are in their third to fourth decade of life
and this tumor carries a good prognosis, with a 5-
year survival rate of up to 97% [6–9]. SPN is
considered to be a tumor with low malignant
potential; however, up to 10–15% of cases have been
reported to be aggressive and can metastasize to the
liver and/or peritoneum [10]. Despite its malignant
potential, resections with no microscopically detected
cancer cell at the resection margin (R0) and en bloc
resections have been reported to improve overall
survival and disease-free survival [11, 12].
The distal pancreas is the most common site of
occurrence, but with advancements in imaging tech-
niques and practices, SPNs located at the uncinate,
head, and neck of the pancreas, referred collectively
henceforth as the proximal pancreas, are now being
increasingly reported [9, 13]. A previous study com-
pared the outcomes of minimally invasive (MI) and
open distal pancreatectomies in patients with SPN
where the outcome favored minimally invasive surgi-
cal approaches (laparoscopic and robot-assisted) [14].
As such, the need to investigate surgical approaches
for SPNs of the proximal pancreas is needed in
order to provide the surgeon with viable options in
the management of all SPNs of the pancreas.
Therefore, the purpose of this study was to compare
the perioperative short-term and long-term outcomes of
minimally invasive (laparoscopic and robotic) and open
surgical approaches of the proximal pancreas in patients
with pathologically confirmed SPNs.
Methods
Data collection
Patients’ medical records were retrospectively reviewed
to identify those who underwent either open or MI pyl-
orus-preserving pancreaticoduodenectomy (PPPD), clas-
sic Whipple procedure (PD), or central pancreatectomy
(CP) for pathologically confirmed SPNs between 2006
and 2017 at the Severance Hospital of the Yonsei Uni-
versity Health System in Seoul, South Korea. Data repre-
senting the clinicopathological characteristics, such as
age, gender, tumor size, and location, were retrospect-
ively collected. Patients who underwent extensive
surgeries or combined resections were excluded from
this study in order to avoid selection bias in the com-
parative analysis between MI and open surgical
approaches.
For the assessment of long-term nutrition, the Con-
trolling Nutritional Status (CONUT) scoring system was
used. The CONUT score utilizes serum albumin, choles-
terol, and total lymphocyte count as parameters to
measure the nutritional status of patients and has been
shown to be predictive of survival in colorectal neo-
plasms [15, 16] and hepatocellular neoplasms [17]. We
stratified the study population into three groups accord-
ing to the year when the surgery was performed (e.g.,
2006–2009, 2010–2013, 2014–2017) to determine the
chronological trends of clinical characteristics in patients
with SPNs. This study protocol was approved by the
local institutional review board, with the IRB number 4-
2018-0001.
Statistical analysis
IBM SPSS Statistics, version 23 (SPSS Inc., Chicago, IL,
USA) was used for the statistical analyses. Continuous
variables were presented as mean ± standard deviation
and categorical variables were represented as percentage
or frequency. Student’s t test was performed to compare
the continuous variables, and Fisher’s exact test or the
chi-squared test was used to compare categorical data
between approaches.
Results
Chronological changes of clinical characteristics according
to period
From 2006 to 2017, 98 patients underwent surgery
for SPN at the Severance Hospital of the Yonsei Uni-
versity Health Systems. Of the 98 patients, 25 were
diagnosed with SPN at the proximal pancreas and
were included in this study. There were no statistical
differences in the age, gender, BMI, and symptoms
across the three periods (Table 1). There was an in-
creasing trend of patients undergoing minimally inva-
sive procedures from the first time period up to the
third time period; however, this was not statistically
significant (p = 0.269). Moreover, the neoplasm stage
at presentation was not statistically significant; how-
ever, it was noted that the size of tumors was smaller
during the period from 2014 to 2017 compared to
the period from 2010 to 2013.
General patient characteristics
Of the 25 patients included in this study, 22 were fe-
male and three were male (female to male ratio was
7.3:1). On average, the patients were 38.2 ± 14.3 years
old and had a BMI of 22.4 ± 2.58 kg/m2. Additionally,
the mean tumor size was 3.51 ± 1.72 cm with a mean
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Table 1 Summary of data per time period
2006–2009 2010–2013 2014–2017 p value
Number 7 11 7
Age (years) 39.43 ± 12.78 35.91 ± 15.42 40.71 ± 15.55 0.775
Gender (F:M) 7:0 9:2 6:1 0.500
BMI (kg/m2) 21.71 ± 2.87 22.82 ± 2.36 22.43 ± 2.88 0.694
Symptomatic
(yes/no)
2/5 5/6 2/5 0.997
Operation type
(MI/open)
2/5 5/6 5/2 0.269
Operation
(PPPD/CP)
3/4 8/3 5/2 0.389
Tumor size (cm) 3.63 ± 1.91 4.12 ± 1.82 2.44 ± 0.78* 0.126
Stage 0.833
Ia 2 (28%) 2 2 (28%)
Ib 5 (72%) 9 5 (72%)
Data are presented as number, mean ± standard deviation, or number (percentage)
F female, M male, BMI body mass index, MI minimally invasive, PPPD pylorus preserving pancreaticoduodenectomy, CP central pancreatectomy
*There was a statistically significant (p = 0.017) decrease in tumor size noted between periods 2010–2013 and 2014–2017
Table 2 Perioperative comparison between minimally invasive and open surgeries
Minimally invasive (n = 13) Open (n = 12) p value
Age (years) 41.0 ± 13.5 35.3 ± 15.4 0.326
Gender (F:M) 11:2 11:1 0.588
Symptomatic
(yes/no)
3/10 6/6 0.161
BMI (kg/m2) 22.8 ± 2.6 21.9 ± 2.5 0.380
Tumor size (cm) 2.6 ± 1.0 4.5 ± 1.8 0.004*
Preoperative stage 0.645
Ia 4 (30.8%) 2 (16.7%)
Ib 9 (69.2%) 10 (83.3%)
Operation 0.411
PPPD 7 (53.8%) 9 (75%)
CP 6 (46.2%) 3 (25%)
OR time (min) 417.2 ± 115.6 413.9 ± 132.4 0.949
Blood loss (mL) 277.7 ± 250.8 664.2 ± 512.4 0.024*
Need for transfusion
(yes/no)
0/13 4/8 0.023*
Pancreas description
(soft/hard)
13/0 12/0
Pancreatic duct
size (mm)
1.15 ± 0.83 1.43 ± 1.2 0.496
Resection type All R0 All R0
Hospital length
of stay (days)
11.5 ± 5.3 27.4 ± 15.3 0.002*
Complication incidence 4 (30.8%) 9 (75%) 0.027*
POPF (grade A/grade B) 2 (15.4%)/2 (15.4%) 3 (25%)/1 (8.33%) 0.465
Data are presented as number, mean ± standard deviation, or number (percentage)
F female, M male, BMI body mass index, PPPD pylorus preserving pancreaticoduodenectomy, CP central pancreatectomy, OR operating room, R0 no
microscopically detected cancer cells at the resection margin, POPF post-operative pancreatic fistula.
*Statistically significant difference between surgical approaches at p < 0.05
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pancreatic duct size of 1.29 ± 1.00 mm. Nine of the
patients presented with symptoms associated with the
tumor, while the tumor was an incidental finding in
the remaining 16 patients. Six (24%) patients pre-
sented as stage Ia and 19 (76%) as stage Ib. Twelve
patients underwent an open surgical procedure and
13 underwent a minimally invasive surgical procedure,
two of which underwent robotic surgery. Nine pa-
tients underwent CP and 16 underwent PPPD. There
were no reported cases of patients who underwent
PD. The patients were followed up for an average of
48.0 ± 31.9 months.
Comparative analysis between MI and open surgical
approaches for SPN of the proximal pancreas
There were no statistically significant differences be-
tween patients who underwent open versus patients who
underwent MI surgeries in terms of age, gender, symp-
tomatic presentation, BMI, preoperative stage, type of
operation, operation time, pancreatic duct size, and
post-operative pancreatic fistula (POPF) grade (p > 0.05
for all; Table 2). All patients underwent an R0 resection
and all remnant pancreata were described to be soft on
palpation. In contrast, tumor size, blood loss, need for
transfusion, hospital length of stay, and complication in-
cidence were significantly greater in open surgery com-
pared to MI surgery (p ≤ 0.027 for all).
Histopathologic outcomes
We compared the histopathologic outcomes of the
patients based on their surgical approach. The col-
lected data is presented in Table 3. During the fol-
low-up period (median, 57 months; range, 4–120
months), none of the patients in this study experi-
enced tumor recurrence or death as a result of the
disease. All pathologic resection margins were nega-
tive for disease. Further, a review of the microscopic
pathologic parameters (capsular invasion, lymphovas-
cular invasion, perineural invasion), as well as the
post-operative stage, revealed that there were no sig-
nificant differences between the surgical approaches.
Long-term nutritional assessment
The CONUT scoring system was used to determine the
nutritional status of patients prior to surgery and 6 and
12months after surgery. Nearly all of the patients had
improvements, and none experienced worsening, in nu-
tritional status (Table 4). No significant changes in nu-
tritional status were detected between the surgical
approaches at 6 and 12months after surgery (p > 0.05
for all, Table 4).
Discussion
In a previous study, we have reported the surgical out-
comes of minimally invasive distal pancreatectomy for
SPN of the pancreas [14]. There are also several litera-
tures reported [18–22] showing favorable perioperative
outcomes in managing SPN of the distal pancreas; how-
ever, minimally invasive surgical procedures (PPPD or
CP) for SPN in the proximal pancreas seems rare.
Patients who underwent open or MI surgeries for
SPN at the proximal pancreas showed no statistically
significant differences in terms of gender, age, BMI,
pancreas characteristics, operation time, and Ameri-
can Joint Committee on Cancer (AJCC) cancer stage.
However, it was demonstrated that patients with MI
surgery had a smaller tumor size at presentation
(mean, 2.6 vs. 4.5 cm, respectively), which may have
been a factor in deciding which surgical approach to
perform in managing SPN of the proximal pancreas.
The study results showed statistically significant dif-
ferences in length of hospital stay, complication inci-
dence, blood loss, and transfusion requirement, all of
which favored the MI surgical approach. These
Table 3 Histopathologic outcomes of minimally invasive and open surgeries
Minimally invasive (n = 13) Open (n = 12) p value
Death associated
with disease
None None
Recurrence None None
Resection margin All negative All negative
Capsular invasion 3 (23.1%) 2 (16.7%) 0.698
Lymphovascular invasion 1 (7.69%) 0 0.327
Perineural invasion 3 (23.1%) 2 (16.7%) 0.689
Stage 0.409
Ia 4 (30.8%) 1 (8.33%)
Ib 6 (46.2%) 9 (75%)
IIa 3 (23.1%) 2 (16.7%)
Data are presented as number (percentage)
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parameters are often used when comparing surgical
procedures and their possible adverse effects on pa-
tients. Needless to say, shorter hospital stay, de-
creased blood loss, and lower need for transfusion are
all positive aspects that advocate for the recommen-
dation of MI surgery in selected patients with SPN of
the proximal pancreas. These findings coincide with
those of Torres et al. who reported a successful lap-
aroscopic pancreaticoduodenectomy in a 19/F with
SPN who was discharged after 6 days without compli-
cation [23]. Similarly, Senthilnathan et al. reported
five successful laparoscopic pancreaticoduodenectomy
operations in their 8-year experience [24].
It should also be noted that there was no residual
tumor after the operation and that all pathological re-
ports indicated margin-free tumors in all cases. This
entails that both open and MI surgical approaches
can deliver comparable long-term results that are
within the oncologic parameters.
The role of nutrition in improving perioperative
outcomes is being recognized increasingly. Several re-
searches describe decreased complications, as well as
improved surgical outcomes, as a direct effect of im-
proving the perioperative nutritional status of the pa-
tient [25–28]. Our study noted that there was an
improvement in the CONUT score of nearly all of
the patients at 6 and 12 months after surgery. How-
ever, there was no statistical difference in the change
of nutritional status between the surgical approaches
(p < 0.05). This implies that both open and MI surgi-
cal approaches can achieve quality of life goals in
managing patients with SPN.
Conclusion
The current first-line treatment for SPN of the pan-
creas remains to be complete excision. Studies have
shown that complete excision can increase overall
survival and disease-free survival. However, as with all
surgical encounters, we must balance these maximal
oncologic practices with minimizing complications
and potential adverse outcomes. This study suggests
that in appropriately selected patients with SPNs
located at the uncinate, head, or neck of the pancreas,
a MI surgical approach offers at least comparable on-
cologic outcomes as an open approach, while demon-
strating decreased complications and decreased
hospital length of stay. We recommend that a larger
comparison be conducted in order to strengthen this
conclusion.
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